Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Summary [January 1976]

Bell, David N. F. and McGilvray, James W. and Oswald, Andrew J. and Simpson, David R. F. and Telford, Richard (1976) Summary [January 1976]. Quarterly Economic Commentary, 1 (3). pp. 1-2. ISSN 0306-7866

PDF (FEC_1_3_1976_Bell-etal1)
Final Published Version

Download (136kB)| Preview


    Prospects for the world economy have greatly improved in the last few months. The key to this recovery lies in the United States, which experienced rapid growth during the second half of 1975. Simultaneously, the rate of price inflation slowed to an annual rate of just under 8%, and the US secured a substantial balance of payments surplus. Although the present situation and the short-run outlook - inevitable consequences of general UK experience during the present cycle of recession - are gloomy, analysis of Scotland's relative performance in this recession provides some grounds for optimism.